Cargando…

A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation

Liver transplantation has become the ultimate treatment for patients with end stage liver disease. However, early allograft dysfunction (EAD) has been associated with allograft loss or mortality after transplantation. We aim to utilize a metabolomic platform to identify novel biomarkers for more acc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Hsin-I, Lo, Chi-Jen, Zheng, Chih-Wen, Lee, Chao-Wei, Lee, Wei-Chen, Lin, Jr-Rung, Shiao, Ming-Shi, Cheng, Mei-Ling, Yu, Huang-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352109/ https://www.ncbi.nlm.nih.gov/pubmed/30597989 http://dx.doi.org/10.3390/jcm8010030

Ejemplares similares

A nomogram for prediction of early allograft dysfunction in living donor liver transplantation
por: Ko, Yu-Chen, et al.
Publicado: (2020)

Uric Acid as a Predictor for Early Allograft Dysfunction after Living Donor Liver Transplantation: A Prospective Observational Study
por: Hu, Li-Min, et al.
Publicado: (2021)

Using Rotational Thromboelastometry to Identify Early Allograft Dysfunction after Living Donor Liver Transplantation
por: Lee, Chen-Fang, et al.
Publicado: (2021)

The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation
por: Chae, Min Suk, et al.
Publicado: (2018)

Lipid Profiling Reveals Lipidomic Signatures of Weight Loss Interventions
por: Lin, Kaiqing, et al.
Publicado: (2023)

Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation
por: Chae, Min Suk, et al.
Publicado: (2018)

Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction
por: Xu, Jin, et al.
Publicado: (2015)

Identifying Biomarkers from Transcriptomic Signatures in Renal Allograft Biopsies Using Deceased and Living Donors
por: Yang, Bin, et al.
Publicado: (2021)

Predictors of decision ambivalence and the differences between actual living liver donors and potential living liver donors
por: Weng, Li-Chueh, et al.
Publicado: (2017)

Metabolic Signature Differentiated Diabetes Mellitus from Lipid Disorder in Elderly Taiwanese
por: Lo, Chi-Jen, et al.
Publicado: (2018)

Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

Correction to: Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

The Human Immune Response to Cadaveric and Living Donor Liver Allografts
por: Hann, Angus, et al.
Publicado: (2020)

Immediate Postoperative Low Platelet Counts After Living Donor Liver Transplantation Predict Early Allograft Dysfunction
por: Li, Lei, et al.
Publicado: (2015)

Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation
por: Yamamoto, Haruchika, et al.
Publicado: (2020)

Integrative lipidomic features identify plasma lipid signatures in chronic urticaria
por: Li, Jie, et al.
Publicado: (2022)

Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse
por: González-Granillo, Marcela, et al.
Publicado: (2019)

LipidSig: a web-based tool for lipidomic data analysis
por: Lin, Wen-Jen, et al.
Publicado: (2021)

Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors
por: Ohara, Stephanie, et al.
Publicado: (2022)

Effect of donor and recipient variables on the long-term live-donor renal allograft survival in children
por: Wafa, Ehab W., et al.
Publicado: (2011)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

The postoperative hepatic artery resistance index after living donor liver transplantation can predict early allograft dysfunction
por: Lv, Tao, et al.
Publicado: (2020)

LC/MS-based untargeted lipidomics reveals lipid signatures of nonpuerperal mastitis
por: Chen, Xiaoxiao, et al.
Publicado: (2023)

Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant
por: Husain, S. Ali, et al.
Publicado: (2021)

Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung Transplantation
por: Saito, Masao, et al.
Publicado: (2018)

Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
por: Huang, Huang, et al.
Publicado: (2021)

HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
por: Zhi, Yixiao, et al.
Publicado: (2021)

Lipidomics and the quest for brainy lipids
por: Legido-Quigley, Cristina
Publicado: (2021)

Metabolomics and Lipidomics Signatures of Insulin Resistance and Abdominal Fat Depots in People Living with Obesity
por: Koay, Yen Chin, et al.
Publicado: (2022)

Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

A lipidomics study reveals hepatic lipid signatures associating with deficiency of the LDL receptor in a rat model
por: Wang, Hong Yu, et al.
Publicado: (2016)

Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk
por: Harm, Tobias, et al.
Publicado: (2023)

Aneurysmectomy with Partial Nephrectomy on a Living Donor Renal Allograft: A Case Report
por: Paloyo, Siegfredo, et al.
Publicado: (2013)

Chronic Allograft Dysfunction
por: Knoop, Christiane, et al.
Publicado: (2011)

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS
por: Blasco, H., et al.
Publicado: (2017)

Lipidomic profiling identifies signatures of metabolic risk
por: Yin, Xiaoyan, et al.
Publicado: (2019)

Lipidomic Analysis of Archival Pathology Specimens Identifies Altered Lipid Signatures in Ovarian Clear Cell Carcinoma
por: Mir, Sartaj Ahmad, et al.
Publicado: (2021)

Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer
por: Kami Reddy, Karthik Reddy, et al.
Publicado: (2022)

Three cases of pancreas allograft dysfunction.
por: Lee, H. K., et al.
Publicado: (2000)

Is the Presence of 2 Renal Allograft Arteries Associated with Adverse Outcomes in Live Donor Kidney Transplantation?
por: Eren, Eryiğit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ecp13lplqgor3ff2o28u6ttd1